Activus and Gifu Pharmaceutical University to collaborate on Activus Pure Nanoparticle Technology June 20, 2011
Durasert-based latanoprost delivery implant enters phase I/II trial in patients with elevated IOP June 17, 2011
Zealand Pharma and Boehringer Ingelheim join to advance new drugs for type 2 diabetes and obesity June 17, 2011
RSS